All Stories

  1. Interleukin Signatures as Prognostic Biomarkers in Ulcerative Colitis: From Immune Pathways to Clinical Prediction
  2. Molecular Studies of TCF4 Gene and Correlation with Late-Onset Fuchs Endothelial Corneal Dystrophy in the Greek Population: A Novel Cost-Effective Diagnostic Algorithm
  3. APOE Genotyping in Cognitive Disorders: Preliminary Observations from the Greek Population
  4. Correlation of intravitreal IL-6 with the formation of epiretinal membrane after successful retinal detachment repair
  5. PON1, APOE and SDF-1 Gene Polymorphisms and Risk of Retinal Vein Occlusion: A Case-Control Study
  6. Risk factors for retinal vein occlusion: Multivariate approach in a case-control study
  7. Grupo de Trabajo de la EFLM sobre Acreditación y Normas ISO/CEN sobre cómo abordar los requisitos de la norma ISO15189 sobre retención de documentación y muestras
  8. EFLM Working Group Accreditation and ISO/CEN standards on dealing with ISO 15189 demands for retention of documents and examination objects
  9. Association of PON1 , APOE and SDF-1 Gene Polymorphisms with Treatment Response to Intravitreal Anti-VEGF Treatment in Patients with Retinal Vein Occlusion
  10. Unravelling the Role of P300 and TMPRSS2 in Prostate Cancer: A Literature Review
  11. Simultaneous determination of procalcitonin and interleukin-6 in human serum samples with a point-of-care biosensing device
  12. Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor
  13. APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population
  14. Molecular biologic milieu in rhegmatogenous retinal detachment and proliferative vitreoretinopathy: a literature review
  15. The importance of aerobic capacity and nutrition in recreational master mountain runners’ performance and race-induced changes in body composition and biochemical blood indices
  16. Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
  17. Global Longitudinal Strain of the Systemic Ventricle Is Correlated with Plasma Galectin-3 and Predicts Major Cardiovascular Events in Adult Patients with Congenital Heart Disease
  18. Validation and verification of examination procedures in medical laboratories: opinion of the EFLM Working Group Accreditation and ISO/CEN standards (WG-A/ISO) on dealing with ISO 15189:2012 demands for method verification and validation
  19. Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system
  20. Frontotemporal dementia spectrum: first genetic screen in a Greek cohort
  21. Th17 serum cytokines in relation to laboratory‐confirmed respiratory viral infection: A pilot study
  22. Documenting metrological traceability as intended by ISO 15189:2012: A consensus statement about the practice of the implementation and auditing of this norm element
  23. A pilot plasma-ctDNA ring trial for the Cobas® EGFR Mutation Test in clinical diagnostic laboratories
  24. Lazaroid (U-74389G) ameliorates lung injury due to lipid peroxidation and nitric oxide synthase-dependent reactive oxygen species generation caused by remote systematic ischemia-reperfusion following thoracoabdominal aortic occlusion
  25. Brain-derived neurotrophic factor (BDNF) in children with ASD and their parents: a 3-year follow-up
  26. Response to the letter to editor: Copeptin and its clinical implications in the setting of vasovagal syncope
  27. Investigation of associations of ARMS2, CD14, and TLR4 gene polymorphisms with wet age-related macular degeneration in a Greek population
  28. Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study
  29. Copeptin levels in patients with vasovagal syncope
  30. AKT2 Gene Polymorphisms, sRANKL/OPG and Hormone Measurements in Polycystic Ovarian Syndrome (PCOS) Women
  31. Development and validation of molecular methodologies to assess PALB2 expression in sporadic breast cancer
  32. Accreditation process in European countries – an EFLM survey
  33. Recommendation for the review of biological reference intervals in medical laboratories
  34. Circulating resistin is a significant predictor of mortality independently from cardiovascular comorbidities in elderly, non-diabetic subjects with chronic kidney disease
  35. Evaluation of a particle enhanced turbidimetric assay for the measurement of neutrophil gelatinase-associated lipocalin in plasma and urine on Architect-8000: Analytical performance and establishment of reference values
  36. Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer
  37. Development of novel real-time PCR methodology for quantification of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens
  38. Non-invasive prenatal testing (NIPT): limitations on the way to become diagnosis
  39. Novel association of FCGR2A polymorphism with age-related macular degeneration (AMD) and development of a novel CFH real-time genotyping method
  40. Flexible Scope for ISO15189 accreditation
  41. Oxidative stress in dry age-related macular degeneration and exfoliation syndrome
  42. Validation of a Real-Time Quantitative Polymerase Chain Reaction Method for the Quantification of 3 Survivin Transcripts and Evaluation in Breast Cancer Tissues
  43. Association of survivin splice variants with prognosis and treatment of breast cancer
  44. Molecular Genetics of Pseudoexfoliation Syndrome (PXFS) and Glaucoma(PXFG)
  45. Serum markers of deranged myocardial collagen turnover: Their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure
  46. Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
  47. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
  48. Biomarkers in primary open angle glaucoma
  49. Human papilloma virus (HPV) molecular diagnostics
  50. Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR
  51. Increased inflammatory Response in Patients With Dilated Cardiomyopathy Is Associated With Dyslipidemia: Effects of Statin Therapy
  52. The Association Between a CommonFCGR2APolymorphism and C-Reactive Protein and Coronary Artery Disease Revisited
  53. PIK3CA Hotspot Mutation Scanning by a Novel and Highly Sensitive High-Resolution Small Amplicon Melting Analysis Method
  54. P374 EPIGENETIC MODIFICATIONS IN HUMAN CAROTID ATHEROMATOUS PLAQUES
  55. Mutation scanning of exon 20 of the BRCA1 gene by high-resolution melting curve analysis
  56. PI3K Pathway Activity and Response to First-Line Chemotherapy in Combination with Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer.
  57. The Effect of Plasma Homocysteine Levels on Clinical Outcomes of Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome
  58. Development of a real-time PCR detection method for a FCGR2A polymorphism in the LightCycler and application in the heparin-induced thrombocytopenia syndrome
  59. Serum oxidizability, total antioxidant status and albumin serum levels in patients with aneurysmal or arterial occlusive disease
  60. Asymmetric real-time PCR detection of BRCA1 5382insC mutation by melting curve analysis in the LightCycler
  61. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece
  62. The beneficial effects of the combined methods in investigating heparin-induced thrombocytopenia
  63. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics
  64. Antiinflammatory Effects of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure
  65. Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart failure improvement
  66. Real-Time Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor Splice Variants
  67. Development and applications of a real-time quantitative RT-PCR method (QRT-PCR) for BRCA1 mRNA
  68. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy
  69. Genetic counseling of medullary breast cancer patients
  70. P-470 Sustained improvement in peripheral immune responses by biventricular pacing and its association with exercise tolerance and quality of life
  71. P-230 The effect of biventricularpacing on serum levels of soluble cellular adhesion molecules is sustained following 3 months of therapy discontinuation
  72. P-168 BNP in biventricular pacing: Its association with functional status and inflammatory markers
  73. Prognostic significance of soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy
  74. 158 Growth hormone treatment reduces circulating inflammatory cytokines and improves left ventricular contractile performance in patients with dilated cardiomyopathy
  75. Atypical Medullary Breast Carcinoma in a Family Carrying the 5382insC BRCA-1 Mutation
  76. Sustained improvement in peripheral immune response by biventricular pacing and its association with exercise tolerance and quality of life
  77. Physical training-induced reduction of peripheral monocyte-related inflammatory markers is associated with improvement in endothelial function of chronic heart failure patients
  78. Immunomodulatory effects of growth hormone administration are associated with improvement in myocardial contractile performance in dilated cardiomyopathy patients
  79. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed
  80. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy
  81. Physical training modulates proinflammatory cytokines and soluble fas-soluble fas ligand system in patients with chronic heart failure
  82. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure
  83. Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations
  84. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure
  85. Immune-genetic control of hyperprolactinemia in patients with heart failure and correlation with ventricular function Dennis Cokkinos, Constantinos Limas, Christos Kroupis, Antigoni Haidaroglou. Onassis Cardiac Surgery Center, Athens, Greece
  86. Cell adhesion molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease
  87. Physical training reduces circulating monocyte-endothelial cell adhesive interaction markers in patients with chronic heart failure
  88. Effects of growth hormone treatment on circulating proinflammatory cytokines and soluble apoptosis receptor Fas in patients with dilated cardiomyopathy
  89. BRCA1 mutation analysis in breast/ovarian cancer families from Greece
  90. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors
  91. Effect of Cyclosporine and Sirolimus on Interleukin-15–Driven Proliferation of OKT3-Preactivated Human Lymphocytes
  92. ATP-dependent Regulation of Sodium-Calcium Exchange in Chinese Hamster Ovary Cells Transfected with the Bovine Cardiac Sodium-Calcium Exchanger
  93. Dimerization of Thermomonospora fusca .beta.-1,4-endoglucanase E2
  94. Cloning and expression of the bovine cardiac sodium-calcium exchanger